1. Home
  2. SLRC vs SANA Comparison

SLRC vs SANA Comparison

Compare SLRC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SLR Investment Corp.

SLRC

SLR Investment Corp.

HOLD

Current Price

$12.64

Market Cap

691.2M

Sector

Finance

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$3.92

Market Cap

793.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLRC
SANA
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
691.2M
793.1M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
SLRC
SANA
Price
$12.64
$3.92
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$15.14
$7.80
AVG Volume (30 Days)
414.4K
2.5M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
10.49%
N/A
EPS Growth
N/A
17.24
EPS
0.47
N/A
Revenue
N/A
N/A
Revenue This Year
$1.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.13
$2.61
52 Week High
$16.75
$6.55

Technical Indicators

Market Signals
Indicator
SLRC
SANA
Relative Strength Index (RSI) 44.82 60.15
Support Level $12.47 $3.82
Resistance Level $13.33 $4.28
Average True Range (ATR) 0.25 0.24
MACD -0.04 0.04
Stochastic Oscillator 22.76 76.97

Price Performance

Historical Comparison
SLRC
SANA

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Share on Social Networks: